These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6833142)

  • 1. Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. III. Absolute stereochemistry.
    Müller JC; Toome V; Pruess DL; Blount JF; Weigele M
    J Antibiot (Tokyo); 1983 Mar; 36(3):217-25. PubMed ID: 6833142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. II. Fermentation, isolation and structure.
    Evans RH; Ax H; Jacoby A; Williams TH; Jenkins E; Scannell JP
    J Antibiot (Tokyo); 1983 Mar; 36(3):213-6. PubMed ID: 6833141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ro 22-5417, a new clavam antibiotic from Streptomyces clavuligerus. I. Discovery and biological activity.
    Pruess DL; Kellett M
    J Antibiot (Tokyo); 1983 Mar; 36(3):208-12. PubMed ID: 6833140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inversion of the stereochemical configuration (3S, 5S)-clavaminic acid into (3R, 5R)-clavulanic acid: A computationally-assisted approach based on experimental evidence.
    Ramirez-Malule H; Restrepo A; Cardona W; Junne S; Neubauer P; Rios-Estepa R
    J Theor Biol; 2016 Apr; 395():40-50. PubMed ID: 26835563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5S clavam biosynthesis is controlled by an atypical two-component regulatory system in Streptomyces clavuligerus.
    Kwong T; Zelyas NJ; Cai H; Tahlan K; Wong A; Jensen SE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4845-55. PubMed ID: 22751548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of clavam metabolites.
    Jensen SE
    J Ind Microbiol Biotechnol; 2012 Oct; 39(10):1407-19. PubMed ID: 22948564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clavulanic acid, a beta-lactamase inhibitor: biosynthesis and molecular genetics.
    Liras P; Rodríguez-García A
    Appl Microbiol Biotechnol; 2000 Oct; 54(4):467-75. PubMed ID: 11092620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis and molecular genetics of clavulanic acid.
    Jensen SE; Paradkar AS
    Antonie Van Leeuwenhoek; 1999; 75(1-2):125-33. PubMed ID: 10422585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5S clavam biosynthetic genes are located in both the clavam and paralog gene clusters in Streptomyces clavuligerus.
    Tahlan K; Anders C; Wong A; Mosher RH; Beatty PH; Brumlik MJ; Griffin A; Hughes C; Griffin J; Barton B; Jensen SE
    Chem Biol; 2007 Feb; 14(2):131-42. PubMed ID: 17317567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the clavam biosynthetic gene clusters in Streptomyces antibioticus Tü1718 and Streptomyces clavuligerus.
    Goomeshi Nobary S; Jensen SE
    Can J Microbiol; 2012 Apr; 58(4):413-25. PubMed ID: 22435762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alanylclavam biosynthetic genes are clustered together with one group of clavulanic acid biosynthetic genes in Streptomyces clavuligerus.
    Zelyas NJ; Cai H; Kwong T; Jensen SE
    J Bacteriol; 2008 Dec; 190(24):7957-65. PubMed ID: 18931110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological, and chiroptical activity of 3-phenyl-clavams.
    Cierpucha M; Solecka J; Frelek J; Szczukiewicz P; Chmielewski M
    Bioorg Med Chem; 2004 Jan; 12(2):405-16. PubMed ID: 14723959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nisamycin, a new manumycin group antibiotic from Streptomyces sp. K106. II. Structure determination and structure-activity relationships.
    Hayashi K; Nakagawa M; Fujita T; Tanimori S; Nakayama M
    J Antibiot (Tokyo); 1994 Oct; 47(10):1110-5. PubMed ID: 7961160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clavulanic acid biosynthesis and genetic manipulation for its overproduction.
    Song JY; Jensen SE; Lee KJ
    Appl Microbiol Biotechnol; 2010 Oct; 88(3):659-69. PubMed ID: 20711575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holomycin and an antibiotic (MM 19290) related to tunicamycin, metabolites of Streptomyces clavuligerus.
    Kenig M; Reading C
    J Antibiot (Tokyo); 1979 Jun; 32(6):549-54. PubMed ID: 468729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereostructure and NMR characterization of the antibiotic candidin.
    Pawlak J; Sowiński P; Borowski E; Gariboldi P
    J Antibiot (Tokyo); 1993 Oct; 46(10):1598-604. PubMed ID: 8244889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of gene replacement technology to Streptomyces clavuligerus strain development for clavulanic acid production.
    Paradkar AS; Mosher RH; Anders C; Griffin A; Griffin J; Hughes C; Greaves P; Barton B; Jensen SE
    Appl Environ Microbiol; 2001 May; 67(5):2292-7. PubMed ID: 11319114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of manumycin. III. Absolute configuration and conformational studies.
    Thiericke R; Stellwaag M; Zeeck A; Snatzke G
    J Antibiot (Tokyo); 1987 Nov; 40(11):1549-54. PubMed ID: 3693125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ccaR, encoding the positive activator of cephamycin C and clavulanic acid production in Streptomyces clavuligerus, is dependent on bldG.
    Bignell DR; Tahlan K; Colvin KR; Jensen SE; Leskiw BK
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1529-41. PubMed ID: 15793135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, absolute stereochemistry and molecular design of the new antifungal and antibacterial antibiotic produced by Streptomyces sp.201.
    Boruwa J; Kalita B; Barua NC; Borah JC; Mazumder S; Thakur D; Gogoi DK; Bora TC
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3571-4. PubMed ID: 15177476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.